TNFSF11 and breast cancer: Other markers have been proposed to assess bone resorption (such as C-terminal telopeptide of type 1 collagen –CTX- or receptor activator of nuclear factor kappa B ligand -RANKL-)22,23 meaning that the measurement of all these biomarkers could also be of interest to people with BC.